US Stock MarketDetailed Quotes

Jasper Therapeutics (JSPR)

Watchlist
  • 0.8501
  • -0.1089-11.36%
Close May 15 16:00 ET
  • 0.8300
  • -0.0201-2.36%
Post 19:57 ET
23.80MMarket Cap-0.33P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Jasper Therapeutics (JSPR) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
36.31%-14.55M
-23.26%-77.16M
-3.47%-21.87M
-20.97%-17M
-32.30%-15.45M
-45.16%-22.84M
-20.23%-62.6M
-28.25%-21.13M
-17.29%-14.05M
12.00%-11.68M
Net income from continuing operations
94.47%-1.17M
-6.36%-75.8M
62.58%-9.1M
-0.53%-18.74M
-83.25%-26.72M
-54.73%-21.24M
-10.55%-71.27M
-46.68%-24.32M
-6.23%-18.64M
9.31%-14.58M
Operating gains losses
----
----
----
----
----
----
-98.09%11K
----
----
----
Depreciation and amortization
-92.47%21K
-23.09%1.06M
18.37%290K
-57.67%229K
-13.71%258K
-3.13%279K
23.92%1.37M
-13.43%245K
96.01%541K
8.73%299K
Other non cash items
-4,998.96%-9.46M
-1,183.10%-5.32M
-4,791.54%-6.1M
118.40%273K
162.50%315K
66.38%193K
22.44%491K
54.76%130K
154.82%125K
137.74%120K
Change In working capital
-12.33%-4.36M
-2,775.54%-4.92M
-1,255.58%-9.73M
-109.73%-187K
786.03%8.88M
-8.46%-3.88M
-96.39%184K
159.17%842K
-53.37%1.92M
-31.37%1M
-Change in receivables
----
----
----
----
----
----
--0
--0
--0
--0
-Change in prepaid assets
2.99%-195K
16.20%-1.78M
-22.35%-2.29M
52.82%-209K
3,382.14%919K
-192.20%-201K
-376.79%-2.12M
-167.14%-1.87M
-131.55%-443K
-107.93%-28K
-Change in payables and accrued expense
-1.91%-3.73M
-179.11%-2.18M
-352.65%-7.01M
-82.45%432K
699.80%8.05M
-4.88%-3.66M
-47.00%2.76M
491.68%2.78M
-15.66%2.46M
-4.46%1.01M
-Change in other current assets
-87.50%36K
35.18%707K
-80.83%37K
-72.00%42K
30.77%340K
460.00%288K
189.55%523K
120.71%193K
341.18%150K
-7.14%260K
-Change in other current liabilities
-51.75%-478K
-71.63%-1.67M
-82.81%-468K
-83.00%-452K
-83.54%-435K
-35.19%-315K
-2.96%-973K
1.54%-256K
-4.66%-247K
-4.41%-237K
Cash from discontinued investing activities
Operating cash flow
36.31%-14.55M
-23.26%-77.16M
-3.47%-21.87M
-20.97%-17M
-32.30%-15.45M
-45.16%-22.84M
-20.23%-62.6M
-28.25%-21.13M
-17.29%-14.05M
12.00%-11.68M
Investing cash flow
Cash flow from continuing investing activities
0
100.94%5K
0
0
100.64%1K
116.00%4K
-99.25%-532K
66.96%-76K
-274K
-1,327.27%-157K
Net PPE purchase and sale
--0
100.94%5K
--0
--0
100.64%1K
116.00%4K
-99.25%-532K
66.96%-76K
---274K
-1,327.27%-157K
Cash from discontinued investing activities
Investing cash flow
--0
100.94%5K
--0
--0
100.64%1K
116.00%4K
-99.25%-532K
66.96%-76K
---274K
-1,327.27%-157K
Financing cash flow
Cash flow from continuing financing activities
-28.55%34.21M
-198.55%-340K
315,322.22%28.39M
3,304.97%6.16M
0
-52.58%47.88M
227.31%345K
-75.00%9K
159.34%181K
Net common stock issuance
----
-28.03%33.97M
--27.51M
--514K
--5.94M
--0
-53.49%47.2M
--0
--0
--0
Proceeds from stock option exercised by employees
----
-64.73%243K
-8,173.62%-27.85M
309,611.11%27.87M
23.20%223K
--0
52.43%689K
1,132.14%345K
-75.00%9K
-49.16%181K
Cash from discontinued financing activities
Financing cash flow
----
-28.55%34.21M
-198.55%-340K
315,322.22%28.39M
3,304.97%6.16M
--0
-52.58%47.88M
227.31%345K
-75.00%9K
159.34%181K
Net cash flow
Beginning cash position
-59.60%29.11M
-17.47%72.05M
-44.77%51.32M
-62.77%39.93M
-58.60%49.22M
-17.47%72.05M
125.78%87.3M
-10.90%92.92M
-7.74%107.24M
-8.42%118.89M
Current changes in cash
36.30%-14.55M
-181.61%-42.95M
-6.43%-22.21M
179.55%11.39M
20.31%-9.29M
-172.30%-22.84M
-131.35%-15.25M
-22.88%-20.87M
-19.86%-14.32M
14.22%-11.66M
End cash Position
-70.41%14.56M
-59.60%29.11M
-59.60%29.11M
-44.77%51.32M
-62.77%39.93M
-58.60%49.22M
-17.47%72.05M
-17.47%72.05M
-10.90%92.92M
-7.74%107.24M
Free cash flow
36.31%-14.55M
-22.19%-77.17M
-3.00%-21.87M
-18.66%-17M
-30.61%-15.46M
-44.93%-22.84M
-20.67%-63.15M
-27.06%-21.23M
-19.57%-14.33M
10.89%-11.84M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 36.31%-14.55M-23.26%-77.16M-3.47%-21.87M-20.97%-17M-32.30%-15.45M-45.16%-22.84M-20.23%-62.6M-28.25%-21.13M-17.29%-14.05M12.00%-11.68M
Net income from continuing operations 94.47%-1.17M-6.36%-75.8M62.58%-9.1M-0.53%-18.74M-83.25%-26.72M-54.73%-21.24M-10.55%-71.27M-46.68%-24.32M-6.23%-18.64M9.31%-14.58M
Operating gains losses -------------------------98.09%11K------------
Depreciation and amortization -92.47%21K-23.09%1.06M18.37%290K-57.67%229K-13.71%258K-3.13%279K23.92%1.37M-13.43%245K96.01%541K8.73%299K
Other non cash items -4,998.96%-9.46M-1,183.10%-5.32M-4,791.54%-6.1M118.40%273K162.50%315K66.38%193K22.44%491K54.76%130K154.82%125K137.74%120K
Change In working capital -12.33%-4.36M-2,775.54%-4.92M-1,255.58%-9.73M-109.73%-187K786.03%8.88M-8.46%-3.88M-96.39%184K159.17%842K-53.37%1.92M-31.37%1M
-Change in receivables --------------------------0--0--0--0
-Change in prepaid assets 2.99%-195K16.20%-1.78M-22.35%-2.29M52.82%-209K3,382.14%919K-192.20%-201K-376.79%-2.12M-167.14%-1.87M-131.55%-443K-107.93%-28K
-Change in payables and accrued expense -1.91%-3.73M-179.11%-2.18M-352.65%-7.01M-82.45%432K699.80%8.05M-4.88%-3.66M-47.00%2.76M491.68%2.78M-15.66%2.46M-4.46%1.01M
-Change in other current assets -87.50%36K35.18%707K-80.83%37K-72.00%42K30.77%340K460.00%288K189.55%523K120.71%193K341.18%150K-7.14%260K
-Change in other current liabilities -51.75%-478K-71.63%-1.67M-82.81%-468K-83.00%-452K-83.54%-435K-35.19%-315K-2.96%-973K1.54%-256K-4.66%-247K-4.41%-237K
Cash from discontinued investing activities
Operating cash flow 36.31%-14.55M-23.26%-77.16M-3.47%-21.87M-20.97%-17M-32.30%-15.45M-45.16%-22.84M-20.23%-62.6M-28.25%-21.13M-17.29%-14.05M12.00%-11.68M
Investing cash flow
Cash flow from continuing investing activities 0100.94%5K00100.64%1K116.00%4K-99.25%-532K66.96%-76K-274K-1,327.27%-157K
Net PPE purchase and sale --0100.94%5K--0--0100.64%1K116.00%4K-99.25%-532K66.96%-76K---274K-1,327.27%-157K
Cash from discontinued investing activities
Investing cash flow --0100.94%5K--0--0100.64%1K116.00%4K-99.25%-532K66.96%-76K---274K-1,327.27%-157K
Financing cash flow
Cash flow from continuing financing activities -28.55%34.21M-198.55%-340K315,322.22%28.39M3,304.97%6.16M0-52.58%47.88M227.31%345K-75.00%9K159.34%181K
Net common stock issuance -----28.03%33.97M--27.51M--514K--5.94M--0-53.49%47.2M--0--0--0
Proceeds from stock option exercised by employees -----64.73%243K-8,173.62%-27.85M309,611.11%27.87M23.20%223K--052.43%689K1,132.14%345K-75.00%9K-49.16%181K
Cash from discontinued financing activities
Financing cash flow -----28.55%34.21M-198.55%-340K315,322.22%28.39M3,304.97%6.16M--0-52.58%47.88M227.31%345K-75.00%9K159.34%181K
Net cash flow
Beginning cash position -59.60%29.11M-17.47%72.05M-44.77%51.32M-62.77%39.93M-58.60%49.22M-17.47%72.05M125.78%87.3M-10.90%92.92M-7.74%107.24M-8.42%118.89M
Current changes in cash 36.30%-14.55M-181.61%-42.95M-6.43%-22.21M179.55%11.39M20.31%-9.29M-172.30%-22.84M-131.35%-15.25M-22.88%-20.87M-19.86%-14.32M14.22%-11.66M
End cash Position -70.41%14.56M-59.60%29.11M-59.60%29.11M-44.77%51.32M-62.77%39.93M-58.60%49.22M-17.47%72.05M-17.47%72.05M-10.90%92.92M-7.74%107.24M
Free cash flow 36.31%-14.55M-22.19%-77.17M-3.00%-21.87M-18.66%-17M-30.61%-15.46M-44.93%-22.84M-20.67%-63.15M-27.06%-21.23M-19.57%-14.33M10.89%-11.84M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +34.01%
Sample Name
Sample Code
 +27.74%
Sample Name
Sample Code
 +26.87%
4
United States Gasoline Fund Lp
UGA
+26.33%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+20.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.54%
Sample Name
Sample Code
 +10.70%
Sample Name
Sample Code
 +6.24%
4
NIO Inc
NIO
+4.27%
5
Hesai
HSAI
+3.89%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -